Vyleesi (Bremelanotide) Efficacy in Hispanic and Latino Patients: Documented Gaps and Pharmacogenomic Considerations
Evidence review of bremelanotide (Vyleesi) efficacy differences in Hispanic / Latino populations, covering RECONNECT trial subgroup data, MC4R pharmacogenomics, metabolic confounders, and practical dosing guidance.
Read clinical review